ATAI Life Sciences N.V.
ATAI
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.66B
Close$
$0.00
100% downside
Current Fair Value
100% downsideOvervalued by 100% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.66 Billion |
|---|---|
| Enterprise Value | $2.62 Billion |
| Dividend Yield | $6.00 (-) |
| Earnings per Share | $-2.91 |
| Beta | 1.57 |
| Outstanding Shares | 226,532,786 |
Return
| Return on Equity | -333.90% |
|---|---|
| Return on Assets | -250.46% |
| Return on Invested Capital | -52.39% |
Valuation & Multiples
| P/E Ratio | -2.39 |
|---|---|
| PEG | -18.88 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 750.19 |
| Enterprise Value to EBIT | -20.82 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 13, 2026
EPS Estimate
$-0.11
Average shareholder expectationRevenue Estimate
$125,000
Average shareholder expectationNext Earnings Call
Expected Date
August 13, 2026
EPS Estimate
$-0.11
Average shareholder expectationRevenue Estimate
$111,111
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 24.30% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.13%▼ 43.16% |
|---|---|
| Total Invested | $13.47M▼ 96.26% |
| Investors Holding | 56▼ 137.00% |
ESG Score
No data
About ATAI Life Sciences N.V.
35 employees